chr11-46721697-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000506.5(F2):​c.316+857T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.142 in 152,104 control chromosomes in the GnomAD database, including 2,500 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.14 ( 2500 hom., cov: 33)

Consequence

F2
NM_000506.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.789

Publications

80 publications found
Variant links:
Genes affected
F2 (HGNC:3535): (coagulation factor II, thrombin) This gene encodes the prothrombin protein (also known as coagulation factor II). This protein is proteolytically cleaved in multiple steps to form the activated serine protease thrombin. The activated thrombin enzyme plays an important role in thrombosis and hemostasis by converting fibrinogen to fibrin during blood clot formation, by stimulating platelet aggregation, and by activating additional coagulation factors. Thrombin also plays a role in cell proliferation, tissue repair, and angiogenesis as well as maintaining vascular integrity during development and postnatal life. Peptides derived from the C-terminus of this protein have antimicrobial activity against E. coli and P. aeruginosa. Mutations in this gene lead to various forms of thrombosis and dysprothrombinemia. Rapid increases in cytokine levels following coronavirus infections can dysregulate the coagulation cascade and produce thrombosis, compromised blood supply, and organ failure. [provided by RefSeq, May 2020]
F2 Gene-Disease associations (from GenCC):
  • thrombophilia due to thrombin defect
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • congenital prothrombin deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.576 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000506.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F2
NM_000506.5
MANE Select
c.316+857T>C
intron
N/ANP_000497.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F2
ENST00000311907.10
TSL:1 MANE Select
c.316+857T>C
intron
N/AENSP00000308541.5
F2
ENST00000530231.5
TSL:5
c.316+857T>C
intron
N/AENSP00000433907.1
F2
ENST00000442468.1
TSL:3
c.286+857T>C
intron
N/AENSP00000387413.1

Frequencies

GnomAD3 genomes
AF:
0.142
AC:
21557
AN:
151986
Hom.:
2488
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0311
Gnomad AMI
AF:
0.0811
Gnomad AMR
AF:
0.236
Gnomad ASJ
AF:
0.0795
Gnomad EAS
AF:
0.593
Gnomad SAS
AF:
0.211
Gnomad FIN
AF:
0.252
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.136
Gnomad OTH
AF:
0.126
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.142
AC:
21572
AN:
152104
Hom.:
2500
Cov.:
33
AF XY:
0.152
AC XY:
11314
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.0310
AC:
1288
AN:
41522
American (AMR)
AF:
0.237
AC:
3628
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0795
AC:
276
AN:
3470
East Asian (EAS)
AF:
0.594
AC:
3071
AN:
5174
South Asian (SAS)
AF:
0.212
AC:
1022
AN:
4826
European-Finnish (FIN)
AF:
0.252
AC:
2657
AN:
10554
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
0.136
AC:
9262
AN:
67956
Other (OTH)
AF:
0.123
AC:
260
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.652
Heterozygous variant carriers
0
911
1822
2732
3643
4554
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
242
484
726
968
1210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.144
Hom.:
7127
Bravo
AF:
0.140
Asia WGS
AF:
0.313
AC:
1086
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.15
DANN
Benign
0.73
PhyloP100
-0.79
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3136441; hg19: chr11-46743247; COSMIC: COSV107335264; COSMIC: COSV107335264; API